000841764 001__ 841764
000841764 005__ 20210129232102.0
000841764 0247_ $$2doi$$a10.1016/j.eplepsyres.2017.12.008
000841764 0247_ $$2ISSN$$a0920-1211
000841764 0247_ $$2ISSN$$a0922-9833
000841764 0247_ $$2pmid$$apmid:29276970
000841764 0247_ $$2WOS$$aWOS:000427337600010
000841764 0247_ $$2altmetric$$aaltmetric:30930386
000841764 037__ $$aFZJ-2018-00068
000841764 082__ $$a610
000841764 1001_ $$0P:(DE-HGF)0$$aMalter, M. P.$$b0$$eCorresponding author
000841764 245__ $$aCerebrospinal fluid findings in non-infectious status epilepticus
000841764 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2018
000841764 3367_ $$2DRIVER$$aarticle
000841764 3367_ $$2DataCite$$aOutput Types/Journal article
000841764 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1515076415_1050
000841764 3367_ $$2BibTeX$$aARTICLE
000841764 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000841764 3367_ $$00$$2EndNote$$aJournal Article
000841764 520__ $$aObjectiveIctal activity itself can cause pathological cerebrospinal fluid (CSF) findings. However, data regarding pathological CSF findings caused by SE itself to date remain scarce. We here evaluated the frequency and specificity of pathological CSF findings in non-infectious SE.MethodsWe performed a retrospective analysis of CSF samples in adult patients with episodes of non-infectious SE, who had been admitted to the Department of Neurology, University Hospital of Cologne. The following parameters were assessed: cell count, protein, and lactate content, CSF/serum glucose quotient (QGlc), disturbances of blood-brain-barrier function assessed by CSF/serum albumin quotient (QAlb), and qualitative intrathecal IgG synthesis assessed by unmatched oligoclonal bands in CSF.ResultsWe analysed 54 episodes of non-infectious SE in which CSF had been obtained. CSF pleocytosis was infrequent (6%). Elevated CSF protein content was present in 44% of all cases, whereas elevated CSF lactate content was found in 23% of the cases. A decreased QGlc was present in 9%. Dysfunction of blood-brain-barrier (BBBD) was the most frequent pathological finding, amounting to 55%. Unmatched oligoclonal bands in CSF were seen in 10% of non-infectious SE.Further analysis revealed that elevated CSF protein content was found predominantly in recfractory SE (p = 0.04). Elevated CSF lactate content was associated with shorter latency between onset of SE and CSF retrieval (p = 0.004), positive history of epilepsy (p = 0.02) and an acute symptomatic etiology (p = 0.04). BBBD was also present more often in acute symptomatic SE (p = 0.001) and was the sole pathological CSF parameter associated with clinical outcome: presence of BBBD was associated with a less favorable outcome (p = 0.02).SignificanceNon-infectious SE itself does not commonly cause CSF pleocytosis. Data suggest that the detection of CSF pleocytosis should prompt further diagnostics for an underlying infectious or neoplastic etiology. In contrast, elevation of CSF protein content and BBBD were found frequently in non-infectious SE.
000841764 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000841764 588__ $$aDataset connected to CrossRef
000841764 7001_ $$0P:(DE-Juel1)136888$$aChoi, S.$$b1
000841764 7001_ $$0P:(DE-Juel1)131720$$aFink, G. R.$$b2
000841764 773__ $$0PERI:(DE-600)2013048-X$$a10.1016/j.eplepsyres.2017.12.008$$gVol. 140, p. 61 - 65$$p61 - 65$$tEpilepsy research$$v140$$x0920-1211$$y2018
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.pdf$$yRestricted
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.gif?subformat=icon$$xicon$$yRestricted
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.jpg?subformat=icon-180$$xicon-180$$yRestricted
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.jpg?subformat=icon-640$$xicon-640$$yRestricted
000841764 8564_ $$uhttps://juser.fz-juelich.de/record/841764/files/1-s2.0-S0920121117303674-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000841764 909CO $$ooai:juser.fz-juelich.de:841764$$pVDB
000841764 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b2$$kFZJ
000841764 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000841764 9141_ $$y2018
000841764 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000841764 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEPILEPSY RES : 2015
000841764 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000841764 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000841764 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000841764 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000841764 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000841764 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000841764 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000841764 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000841764 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000841764 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000841764 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000841764 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000841764 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000841764 920__ $$lyes
000841764 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000841764 980__ $$ajournal
000841764 980__ $$aVDB
000841764 980__ $$aI:(DE-Juel1)INM-3-20090406
000841764 980__ $$aUNRESTRICTED